Cidara Thera (CDTX)

The overall ratings of 40 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Hottest Manufacturing Stocks Now – LPCN AXGN RETA CHRS

By Portfolio Grader Oct 7, 2016

The following stocks were moving the Manufacturing sector today.

Hottest Manufacturing Stocks Now – SSNI INNL VBLT SPHS

By Portfolio Grader Jun 30, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

Hottest Manufacturing Stocks Now – JAGX GBIM PRTK TROX

By Portfolio Grader Jun 17, 2016

The following stocks were moving the Manufacturing sector today.

19 Biotechnology Stocks to Sell Now

By Portfolio Grader May 23, 2016

This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Cidara to Present at Mycology 2021 Conference

From BusinessInsider Jun 2, 2021

SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeuti...

Cidara Therapeutics (CDTX) Reports Q1 Loss, Lags Revenue Estimates

From Zacks Investment Research May 13, 2021

Cidara Therapeutics (CDTX) delivered earnings and revenue surprises of -129.41% and -83.95%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Could Johnson & Johnson Be a Big Winner in the Flu Vaccine Market?

From The Motley Fool Apr 14, 2021

Maybe, but there's a long way to go.

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

From Benzinga May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza

From Talk Markets Apr 5, 2021

Cidara is developing a new generation of immunotherapeutic antivirals from its Cloudbreak® antiviral platform that couple potent antivirals to a human antibody fragment.

Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

From Talk Markets Apr 5, 2021

Cidara is developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections.

ON THE DIP

Cidara Thera (CDTX)

6 Cheap Stocks to Buy Under $7

7 Stocks the Insiders Are Buying on Sale

Biggest Movers in Manufacturing Stocks Now – VCEL AUPH ONVO CC

40 Biotechnology Stocks to Sell Now

Louis Navellier's Top 6 Stocks for 2021

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ON THE DIP

Cidara Thera (CDTX)

Louis Navellier's Top 6 Stocks for 2021

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

CDTX Stock Predictions, Articles, and Cidara Thera News

Subscriber Sign in